Tag: AI in trials

KPIs, Dashboards and Scorecards to Track Technology Adoption Curves in Clinical Trials Introduction to Technology Adoption in Clinical Trials The landscape of clinical trials is rapidly evolving with the introduction of innovative technologies such as Artificial Intelligence (AI), Decentralized Trials (DCT), and electronic source data (eSource). This transformation necessitates a robust framework to monitor and…

Read More “KPIs, Dashboards and Scorecards to Track Technology Adoption Curves (AI, DCT, eSource)” »

Vendor, Site and Partner Negotiation Tactics Driven by Technology Adoption Curves (AI, DCT, eSource) Vendor, Site and Partner Negotiation Tactics Driven by Technology Adoption Curves (AI, DCT, eSource) In recent years, the landscape of drug development and clinical trials has been dramatically reshaped by advancements in technology. With the adoption of artificial intelligence (AI), decentralized…

Read More “Vendor, Site and Partner Negotiation Tactics Driven by Technology Adoption Curves (AI, DCT, eSource)” »

Scenario Planning: Best-Case and Worst-Case Technology Adoption Curves (AI, DCT, eSource) Outlooks Scenario Planning: Best-Case and Worst-Case Technology Adoption Curves (AI, DCT, eSource) Outlooks The landscape of clinical trials continues to evolve, influenced by advancements in technology, regulatory environments, and the constant pursuit of enhanced patient outcomes. This article aims to conduct a comprehensive analysis…

Read More “Scenario Planning: Best-Case and Worst-Case Technology Adoption Curves (AI, DCT, eSource) Outlooks” »

Investor, Board and C-Suite Questions Around Technology Adoption Curves (AI, DCT, eSource)—Answered Understanding Technology Adoption Curves in Clinical Trials The integration of advanced technologies in clinical trials, particularly Artificial Intelligence (AI), Decentralized Trials (DCT), and electronic Source (eSource) data capture, is transforming the landscape of clinical research. Understanding the adoption curves for these technologies is…

Read More “Investor, Board and C-Suite Questions Around Technology Adoption Curves (AI, DCT, eSource)—Answered” »

Future Trends: AI, RWE and New Business Models in Technology Adoption Curves (AI, DCT, eSource) In the evolving landscape of clinical trials, understanding the technologies influencing the adoption and integration of new methodologies has become paramount. This article serves as an in-depth tutorial on anticipated trends, specifically around artificial intelligence (AI), real-world evidence (RWE), and…

Read More “Future Trends: AI, RWE and New Business Models in Technology Adoption Curves (AI, DCT, eSource)” »

Digital Tools and Analytics to Forecast and Monitor Technology Adoption Curves (AI, DCT, eSource) Digital Tools and Analytics to Forecast and Monitor Technology Adoption Curves (AI, DCT, eSource) The evolution of technology in clinical trials has seen a rapid transformation over the last decade, driven by the increasing demand for more efficient and patient-centric methodologies….

Read More “Digital Tools and Analytics to Forecast and Monitor Technology Adoption Curves (AI, DCT, eSource)” »

Risk Scenarios and Sensitivity Analyses for Technology Adoption Curves (AI, DCT, eSource) Risk Scenarios and Sensitivity Analyses for Technology Adoption Curves (AI, DCT, eSource) In the rapidly evolving landscape of clinical research, the incorporation of novel technologies like Artificial Intelligence (AI), decentralized clinical trials (DCT), and eSource data collection has reshaped methodologies and operational frameworks….

Read More “Risk Scenarios and Sensitivity Analyses for Technology Adoption Curves (AI, DCT, eSource)” »

Regulatory and Policy Shifts Reshaping Technology Adoption Curves (AI, DCT, eSource) in the US, EU and UK Regulatory and Policy Shifts Reshaping Technology Adoption Curves (AI, DCT, eSource) in the US, EU and UK The rapid evolution and integration of technology within clinical trials have redefined how drug development occurs globally. As clinical operations, regulatory…

Read More “Regulatory and Policy Shifts Reshaping Technology Adoption Curves (AI, DCT, eSource) in the US, EU and UK” »

Using Real-World Data to Inform Technology Adoption Curves (AI, DCT, eSource) Decisions In the evolving landscape of clinical research, the integration of technology such as Artificial Intelligence (AI), decentralized clinical trials (DCT), and eSource has become pivotal in enhancing data collection and patient engagement. However, the adoption of such technologies must be informed by robust…

Read More “Using Real-World Data to Inform Technology Adoption Curves (AI, DCT, eSource) Decisions” »

Governance Models and Cross-Functional Ownership for Technology Adoption Curves (AI, DCT, eSource) The implementation of innovative technologies in clinical trials, such as Artificial Intelligence (AI), Decentralized Trials (DCT), and eSource solutions, is rapidly evolving the landscape of clinical research. This article will provide a comprehensive, step-by-step guide on governance models and the importance of cross-functional…

Read More “Governance Models and Cross-Functional Ownership for Technology Adoption Curves (AI, DCT, eSource)” »